LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "roche" as a keyword



Photo by victor_g from unsplash

BET INHIBITOR RG6146, VENETOCLAX, AND RITUXIMAB IS A HIGHLY ACTIVE REGIMEN IN RELAPSED/REFRACTORY (R/R) DLBCL: INITIAL REPORT OF PHASE 1B SAFETY, BIOMARKER, AND RESPONSE DATA

Sign Up to like & get
recommendations! Published in 2019 at "Hematological Oncology"

DOI: 10.1002/hon.131_2629

Abstract: sultant Advisory Role: Acerta Pharma, Bayer, Celgene, Gilead Sciences, Janssen, Novartis, Roche, and Sandoz; Honoraria: Bayer, Celgene, Gilead Sciences, Janssen, and Roche; Research Funding: Celgene, Janssen, Mundipharma, and Roche; Other Remuneration: Travel, accommodations and expenses… read more here.

Keywords: roche; verastem bms; msd johnson; bms msd ... See more keywords
Photo by _louisreed from unsplash

ARGO: A RANDOMISED PHASE II STUDY OF ATEZOLIZUMAB WITH RITUXIMAB, GEMCITABINE AND OXALIPLATIN IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA WHO ARE NOT CANDIDATES FOR HIGH‐DOSE THERAPY

Sign Up to like & get
recommendations! Published in 2019 at "Hematological Oncology"

DOI: 10.1002/hon.1_2632

Abstract: Roche, Janssen, Takeda, MSD, Gilead, Bristol Myers Squibb, AstraZenecca; Research Funding: Celgene, Roche, Abbvie; Other Remuneration: Roche, Amgen. Chu, M: Honoraria: AstraZeneca, Gilead, Celgene. Dreyling, M: Honoraria: Bayer, Celgene, Gilead, Janssen, Roche, Acerta, Bayer, Celgene,… read more here.

Keywords: janssen; roche; research funding; celgene ... See more keywords
Photo from wikipedia

PHASE III RANDOMIZED STUDY OF ENZASTAURIN/R‐CHOP VS PLACEBO/R‐CHOP IN FRONTLINE HIGH RISK DIFFUSE LARGE B CELL LYMPHOMA PATIENTS WITH GENOMIC BIOMARKER DGM1 (ENGINE STUDY)

Sign Up to like & get
recommendations! Published in 2019 at "Hematological Oncology"

DOI: 10.1002/hon.37_2629

Abstract: Karyopharm Therapeutics, Kite Pharma, Lundbeck, Merck, Roche/Genentech, Inc., Seattle Genetics, Takeda, Teva, TG Therapeutics; Research Funding: Roche/Genentech, Inc. Sharman, J: Consultant Advisory Role: Pharmacyclics, Celgene, TG Therapeutics, Genentech, Inc., AbbVie, Acerta Pharma/AstraZeneca; Research Funding: Pharmacyclics,… read more here.

Keywords: gilead sciences; study; genentech inc; oncology ... See more keywords
Photo from wikipedia

EFFICACY AND SAFETY OF PROLONGED MAINTENANCE WITH SUBCUTANEOUS RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY INDOLENT NHL: RESULTS OF THE PHASE III MABCUTE STUDY

Sign Up to like & get
recommendations! Published in 2019 at "Hematological Oncology"

DOI: 10.1002/hon.43_2630

Abstract: Pharma/Astra Zeneca, Celgene. Janssen; Honoraria: Abbvie, Acerta Pharma/Astra Zeneca, Celgene. Janssen, Gilead Sciences, Roche/Genentech, TG Therapeutics; Research Funding: Acerta Pharma/Astra Zeneca, Janssen, Celgene. Trneny, M: Consultant Advisory Role: Takeda, BMS, Incyte, Abbvie, Amgen, Roche, Gilead,… read more here.

Keywords: hematology; advisory role; celgene; consultant advisory ... See more keywords
Photo by nightcrawler1986 from unsplash

IMPACT OF MAJOR GENOMIC ALTERATIONS ON OUTCOME OF RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS RECEIVING VENETOCLAX PLUS RITUXIMAB IN THE PHASE 3 MURANO STUDY

Sign Up to like & get
recommendations! Published in 2019 at "Hematological Oncology"

DOI: 10.1002/hon.69_2629

Abstract: Position: F. Hoffmann La Roche Ltd; Stock Ownership: F. Hoffmann La Roche Ltd. Ritgen, M: Consultant Advisory Role: Roche, Abbvie; Research Funding: Roche, Abbvie; Other Remuneration: Personal Fees: Roche. Tausch, E: Consultant Advisory Role: Roche;… read more here.

Keywords: advisory role; remuneration; roche abbvie; consultant advisory ... See more keywords
Photo from wikipedia

AN UNDETECTABLE PB MRD STATUS SHOULD BE THE THERAPEUTIC GOAL WITH VENETOCLAX THERAPY IN RELAPSED/ REFRACTORY CLL

Sign Up to like & get
recommendations! Published in 2019 at "Hematological Oncology"

DOI: 10.1002/hon.70_2629

Abstract: Genentech; Stock Ownership: Hoffmann–La Roche. Boyer, M: Employment Leadership Position: Roche; Stock Ownership: Roche. Humphrey, K: Employment Leadership Position: Roche; Stock Ownership: Roche. Jiang, Y: Employment Leadership Position: Genentech; Stock Ownership: Genentech. Kater, A: Consultant… read more here.

Keywords: employment leadership; roche; stock ownership; leadership position ... See more keywords
Photo by victor_g from unsplash

Serum biotin interference: A troublemaker in hormone immunoassays.

Sign Up to like & get
recommendations! Published in 2021 at "Clinical biochemistry"

DOI: 10.1016/j.clinbiochem.2021.10.011

Abstract: OBJECTIVES Biotin therapy can affect the results of many immunoassay procedures. The present study investigates biotin's interference on 25-hydroxy vitamin D(25-OHD), parathyroidhormone(PTH) and thyroid-stimulating hormone(TSH) tests using four different assay systems and biotin neutralization. DESIGN… read more here.

Keywords: roche assay; biotin; biotin interference; neutralization ... See more keywords
Photo by john_cameron from unsplash

West African Crystalline Maculopathy in a Nigerian Woman.

Sign Up to like & get
recommendations! Published in 2018 at "Ophthalmology"

DOI: 10.1016/j.ophtha.2017.11.022

Abstract: Originally received: March 28, 2017. Final revision: July 21, 2017. Accepted: August 30, 2017. Available online: October 27, 2017. Manuscript no. 2017-714. 1 Department of Ophthalmology, University of Bonn, Bonn, Germany. 2 Department of Ophthalmology… read more here.

Keywords: new york; roche; ophthalmology; genentech inc ... See more keywords
Photo by teveir from unsplash

Evaluation of the Sentinel-FOB gold faecal immunochemical test for the presence of haemoglobin using the automated Roche Cobas 8000 system

Sign Up to like & get
recommendations! Published in 2022 at "Practical Laboratory Medicine"

DOI: 10.1016/j.plabm.2022.e00263

Abstract: Objectives Faecal immunochemical tests (FIT) for the detection of haemoglobin are widely used in the diagnostic pathway of colorectal cancer (CRC) in patients presenting with lower abdominal symptoms. Several quantitative immunochemical tests are available, however… read more here.

Keywords: fob gold; system; roche; sentinel fob ... See more keywords
Photo by nci from unsplash

Infection with multiple hepatitis C virus genotypes detected using commercial tests should be confirmed using next generation sequencing

Sign Up to like & get
recommendations! Published in 2019 at "Scientific Reports"

DOI: 10.1038/s41598-019-42605-z

Abstract: Current HCV genotyping methods may have some limitations in detecting mixed infections. We aimed to determine the accuracy of genotyping and the detection of mixed-genotype infections using the Abbott-RealTime HCV Genotype II assay (Abbott-RT-PCR) in… read more here.

Keywords: roche ngs; generation sequencing; abbott pcr; next generation ... See more keywords
Photo by victor_g from unsplash

Analytical comparability demonstrated for an IgG4 molecule, inclacumab, following transfer of manufacturing responsibility from Roche to Global Blood Therapeutics

Sign Up to like & get
recommendations! Published in 2022 at "Expert Opinion on Biological Therapy"

DOI: 10.1080/14712598.2022.2143260

Abstract: ABSTRACT Background Inclacumab is a recombinant, fully human, immunoglobulin IgG4 monoclonal antibody that selectively binds to P-selectin. Initially discovered and developed by Roche through phase 2 clinical studies in peripheral arterial disease and coronary artery… read more here.

Keywords: analytical comparability; roche; inclacumab; global blood ... See more keywords